Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Chlosta

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Healthcare (Basel, Switzerland)|June 2, 2021
Nocturia at the Population Level in Poland: Prevalence, Bother, Quality of Life, and Treatment-Related BehaviorMikolaj Przydacz, Piotr Chlosta
European Urology|October 1, 2008
Re: Hervé Baumert, Mehrak Hekmati, Irene Dunia, et al. Laparoscopy in ureteral engineering: a feasibility study. Eur Urol 2008;54:1154-63Tomasz Drewa, Piotr Chlosta
European Urology|October 27, 2009
Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44Tomasz Drewa, Piotr Chlosta
European Urology|August 16, 2008
Re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist Cetrorelix in patients with symptomatic benign prostatic hyperplasia. Eur Urol 2008;54:170-80Tomasz Drewa, Piotr Chlosta
Central European Journal of Urology|May 2, 2025
LUTS POLAND: The first population-based study of prevalence, bother, and treatment-related behaviour for lower urinary tract symptoms and overactive bladder in Eastern EuropeMikolaj Przydacz, Piotr Chlosta
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 8, 2019
How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinAMikolaj Przydacz, Tomasz Golabek, Piotr Chlosta
Journal of Clinical Medicine|June 2, 2021
Population-Level Prevalence, Bother, and Treatment Behavior for Urinary Incontinence in an Eastern European Country: Findings from the LUTS POLAND StudyMikolaj Przydacz, Marcin Chlosta, Piotr Chlosta
Journal of Clinical Medicine|December 23, 2020
Prevalence, Bother and Treatment Behavior Related to Lower Urinary Tract Symptoms and Overactive Bladder among Cardiology PatientsMikolaj Przydacz, Przemyslaw Dudek, Piotr Chlosta
International Urology and Nephrology|August 4, 2018
Response to the Letter to the editorMikolaj Przydacz, Piotr Chlosta, Jacques Corcos
Surgical Innovation|July 27, 2010
Will tissue-engineered urinary bladders change indications for a laparoscopic cystectomy?Tomasz Drewa, Piotr Chlosta, Rafal Czajkowski
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Healthcare (Basel, Switzerland)|June 2, 2021
Nocturia at the Population Level in Poland: Prevalence, Bother, Quality of Life, and Treatment-Related BehaviorMikolaj Przydacz, Piotr Chlosta
European Urology|October 1, 2008
Re: Hervé Baumert, Mehrak Hekmati, Irene Dunia, et al. Laparoscopy in ureteral engineering: a feasibility study. Eur Urol 2008;54:1154-63Tomasz Drewa, Piotr Chlosta
European Urology|October 27, 2009
Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44Tomasz Drewa, Piotr Chlosta
European Urology|August 16, 2008
Re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist Cetrorelix in patients with symptomatic benign prostatic hyperplasia. Eur Urol 2008;54:170-80Tomasz Drewa, Piotr Chlosta
Central European Journal of Urology|May 2, 2025
LUTS POLAND: The first population-based study of prevalence, bother, and treatment-related behaviour for lower urinary tract symptoms and overactive bladder in Eastern EuropeMikolaj Przydacz, Piotr Chlosta
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 8, 2019
How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinAMikolaj Przydacz, Tomasz Golabek, Piotr Chlosta
Journal of Clinical Medicine|June 2, 2021
Population-Level Prevalence, Bother, and Treatment Behavior for Urinary Incontinence in an Eastern European Country: Findings from the LUTS POLAND StudyMikolaj Przydacz, Marcin Chlosta, Piotr Chlosta
Journal of Clinical Medicine|December 23, 2020
Prevalence, Bother and Treatment Behavior Related to Lower Urinary Tract Symptoms and Overactive Bladder among Cardiology PatientsMikolaj Przydacz, Przemyslaw Dudek, Piotr Chlosta
International Urology and Nephrology|August 4, 2018
Response to the Letter to the editorMikolaj Przydacz, Piotr Chlosta, Jacques Corcos
Surgical Innovation|July 27, 2010
Will tissue-engineered urinary bladders change indications for a laparoscopic cystectomy?Tomasz Drewa, Piotr Chlosta, Rafal Czajkowski
Pageof 12